MML Investors Services LLC purchased a new stake in Davita Inc (NYSE:DVA) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,693 shares of the company’s stock, valued at approximately $408,000.
Other large investors have also bought and sold shares of the company. Green Square Capital LLC purchased a new stake in Davita in the second quarter valued at $208,000. Seven Eight Capital LP purchased a new stake in Davita in the third quarter valued at $219,000. Private Advisor Group LLC purchased a new stake in shares of Davita during the 3rd quarter worth about $249,000. NumerixS Investment Technologies Inc boosted its stake in shares of Davita by 123.7% during the 2nd quarter. NumerixS Investment Technologies Inc now owns 3,600 shares of the company’s stock worth $253,000 after acquiring an additional 1,991 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in shares of Davita by 206.8% during the 2nd quarter. Assetmark Inc. now owns 3,860 shares of the company’s stock worth $268,000 after acquiring an additional 2,602 shares in the last quarter. 85.76% of the stock is currently owned by institutional investors.
Several equities research analysts have recently issued reports on the stock. Raymond James lowered shares of Davita from an “outperform” rating to a “market perform” rating and set a $63.44 target price on the stock. in a research note on Sunday, December 2nd. UBS Group assumed coverage on shares of Davita in a research note on Thursday, November 15th. They set a “sell” rating and a $64.00 target price on the stock. Zacks Investment Research lowered shares of Davita from a “hold” rating to a “sell” rating in a research note on Tuesday, November 13th. TheStreet lowered shares of Davita from a “b-” rating to a “c+” rating in a research note on Thursday, November 8th. Finally, Royal Bank of Canada increased their target price on shares of Davita from $70.00 to $78.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 8th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. Davita has a consensus rating of “Hold” and a consensus target price of $80.16.
DVA stock opened at $61.82 on Friday. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.82 and a current ratio of 1.84. Davita Inc has a 52-week low of $58.68 and a 52-week high of $80.71. The stock has a market cap of $10.64 billion, a PE ratio of 17.90, a PEG ratio of 0.85 and a beta of 1.07.
Davita (NYSE:DVA) last posted its earnings results on Wednesday, November 7th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.33). Davita had a return on equity of 13.87% and a net margin of 5.39%. The firm had revenue of $2.85 billion for the quarter, compared to analysts’ expectations of $2.93 billion. During the same period in the previous year, the company earned $0.81 earnings per share. The company’s revenue was up 3.0% compared to the same quarter last year. Sell-side analysts forecast that Davita Inc will post 3.56 earnings per share for the current fiscal year.
WARNING: “MML Investors Services LLC Purchases Shares of 5,693 Davita Inc (DVA)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/12/07/mml-investors-services-llc-purchases-shares-of-5693-davita-inc-dva.html.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Story: What is a stock split?
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.